[Symptomatic hypokalemia caused by meglumine antimoniate].
Bouvresse
S
S
Matichard
E
E
Mahé
E
E
Marinho
E
E
Soria
A
A
Devillière
M
M
Descamps
V
V
Crickx
B
B
D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced*; D007273:Injections, Intramuscular; D007896:Leishmaniasis / Q000188:drug therapy*; D008536:Meglumine / Q000008:administration & dosage / Q000009:adverse effects*; D000077485:Meglumine Antimoniate; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000009:adverse effects*
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate